BCSVX | PAHWX | BCSVX / PAHWX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 9 years | 3 years | - |
Gain YTD | 7.060 | 14.446 | 49% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000 | 1000 | 500% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.2B | 10.8M | 20,343% |
Annual Yield % from dividends | 0.00 | 0.10 | - |
Returns for 1 year | 18.89 | 21.02 | 90% |
Returns for 3 years | -16.23 | -15.00 | 108% |
Returns for 5 years | 39.36 | N/A | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
WRLDX | 37.89 | 0.21 | +0.56% |
Scharf Global Opportunity Institutional | |||
GCIAX | 14.35 | N/A | N/A |
Goldman Sachs Intl Eq Insghts A | |||
JIESX | 14.85 | N/A | N/A |
JPMorgan Developed International Value I | |||
SHSAX | 68.32 | N/A | N/A |
BlackRock Health Sciences Opps Inv A | |||
NEMCX | 19.28 | -0.08 | -0.41% |
Neuberger Berman Emerg Mkts Eq C |